Just Released: "Metabolomic Technologies Inc. - Product Pipeline Analysis, 2013 Update"
Metabolomic Technologies Inc. (MTI) is a biotechnology company. The company develops diagnostic tests to detect adenomatous polyps and colorectal cancer. Its products include variety of diagnostics. MTI offers products under various brands such as BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx, IBDDx, LactoseDx, RefluxDx and UlcerDx. The company offers biomarker validation services. Its products are used to treat breast cancer, prostate cancer, celiac disease, ulcerative colitis, Crohn's Disease, IBD, lactose intolerance, acid reflux and gastric ulcers. The company conducts research and development...
View full press release